Previous Page  24 / 38 Next Page
Information
Show Menu
Previous Page 24 / 38 Next Page
Page Background

Page 81

allied

academies

Ann Biol Sci, 2017

ISSN: 2348-1927

August 23-24, 2017 | Toronto, Canada

Annual Conference on

MICROBIAL PATHOGENESIS, INFECTIOUS DISEASE,

ANTIMICROBIALS AND DRUG RESISTANCE

Background:

Different delivery modes may affect the

susceptibility to allergic diseases. It is still unknown whether

early intervention with probiotics would counteract this

effect.

Objectives:

The effect of different delivery modes on

immune status and nasal symptoms was investigated on

established allergic rhinitis (AR) mouse model. In addition,

the immunoregulatory effects and mechanisms of different

feeding manners with

Bifidobacterium breve (B. breve)

were

examined.

Methods:

Live lyophilized

B. breve

was orally administered

to BALB/c mice born via vaginal delivery(VD) or cesarean

delivery (CD) for 8 consecutive weeks, after which they were

sensitized by ovalbumin (OVA) to establish experimental AR.

Nasal symptoms, serum immunoglobulins, cytokines, splenic

percentages of CD4+ CD25+ Foxp3+ regulatory T(Treg) cells

and nasal eosinophil infiltration were evaluated.

Results:

Compared with VD mice, mice delivered via

CD demonstrated more serious nasal symptoms, higher

concentrations of OVA-specific immunoglobulin (Ig) E, more

nasal eosinophils and lower percentages of splenic CD4+

CD25+ Foxp3+ Treg cells after establishing experimental AR.

These parameters were reversed by administering

B. breve

shortly after birth. However, the effect of

B. breve

did not

differ between different delivery modes.

Conclusion:

CD aggravates the nasal symptoms of AR

mice compared to VD. This is the first report that oral

administration of

B. breve

shortly after birth can significantly

alleviate the symptoms of AR mice born via both deliveries,

probably via activation of the regulatory capacity of CD4+

CD25+ Foxp3+ Treg cells.

e:

672092965@qq.com

Effects of

Bifidobacterium

breve feeding strategy and delivery modes on experimental allergic rhinitis

mice

Jian-jun Ren

1

, Yu Zhao

1

, Feng-Ling Yang

1

, Dan LV

1

, Shi Hung

1

, Jie Zhang

1

, Ping Lin

1

, Shi-Xi Liu

1

, Nan Zhang

2

and

Claus Bachert

2

1

Sichuan University, China

2

Ghent University, Belgium

Arch Clin Microbiol, 8:5

DOI: 10.4172/1989-8436-C1-003